Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conventional Medicine vs TCM vs Combination in COPD
NCT01836016Phase 3Unknown
- Sponsor
- Henan University of Chinese Medicine
- Start
- May 2013
- Primary completion
- May 2015
- Modality
- TCM (Traditional Chinese Medicine), HM (Herbal Medicine)
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of bufei fang, bufei yishen granule and Yi-Qi Zi-Shen in chronic obstructive pulmonary disease (COPD) (3 arms), sponsored by Henan University of Chinese Medicine. Primary endpoint: Frequency of Exacerbations at 52 weeks. Status: unknown.
02
Drugs
bufei fangbufei yishen granuleYi-Qi Zi-Shen
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01836016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01836016.